Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY: CYBN )

9.530 +0.060 (+0.63%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 14, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49 
Via Benzinga
Is It Safe to Smoke DMT?
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From July 13, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61 
Via Benzinga
Online Companies Offering Mental Health Services Come Under Spotlight
Via Investor Brand Network
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment
Via Investor Brand Network
Psychedelic Drug Stocks Index Up Last Week, Still Down YTD
The psychedelic Compounds-Based Drug Stocks Index was +24.0% last week; +33.5% in the last 5 weeks; but still -44.0% YTD. 
Via Talk Markets
Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
From Clinilabs Drug Development Corporation
Via Business Wire
Psychedelic Stock Gainers And Losers From July 11, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54 
Via Benzinga
Congressional Leaders Want Studies to be Conducted on Mental Health Benefits of Psychedelics
Via Investor Brand Network
Topics Law Enforcement
Exposures Legal
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
Via Investor Brand Network
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical
From Cybin Inc.
Via Business Wire
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.74% at $12.85 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 7, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.62% at $0.54 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 6, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 20.50% at $0.89 
Via Benzinga
Archaeologists Believe Hidden Andean Passageways Were Most Likely Used During Psychedelic Rituals
Via Investor Brand Network
Numinus Wellness, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 13.88% at $0.20 
Via Benzinga
New Study Finds That Probiotics May Be Useful in Fight Against Depression
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From July 1, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.17% at $0.50 
Via Benzinga
June Update: Psychedelic Compounds-Based Drug Stocks Index Up 8%; Down 55% YTD
The psychedelic Compounds-Based Drug Stocks Index was up 7.7% in June but is still down 54.9% YTD. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From June 30, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $10.82 
Via Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.77% at $0.69 
Via Benzinga
NJ Senate President Introduces Psilocybin Legalization Bill Containing Home-Cultivation Provision
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.03% at $0.85 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone
Via Investor Brand Network
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
Psychedelic biopharma company Cybin Inc. (NEO: CYBN) has received FDA Investigational New Drug Application (IND) approval for a Phase 1/2a clinical trial evaluating its proprietary CYB003 for treating... 
Via Benzinga
Cybin Announces Additional Adelia Milestone Achievement
From Cybin Inc.
Via Business Wire
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.